Results 111 to 120 of about 110,652 (302)

Note from Sister Martha Anderson, Greenfield, Massachusetts, to Mercy A. Anderson, Mount Holyoke Female Seminary, South Hadley, Massachusetts, February 21, 1869

open access: yes
A letter to Mercy A. Anderson, a student at Mt. Holyoke Female Seminary in South Hadley, Massachusetts, from her sister describing home and wishing her well with her ...
Anderson, Martha
core  

Characterization of NAT2 Using Long‐Read Sequencing: Allele, Diplotype, and Phenotype Call Accuracy Compared to Other Testing Strategies

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The NAT2 pharmacogene is essential in drug metabolism, particularly for aromatic amines and hydrazines. Genetic variations in NAT2 categorize individuals as rapid, intermediate, or poor metabolizers based on their acetylation capacity to inform dosing guidelines.
Shobana John   +4 more
wiley   +1 more source

Children\u27s Mercy Annual Report 2018

open access: yes, 2018
Annual report for The Children\u27s Mercy Hospital in Kansas City MO, a pediatric medical center.https://scholarlyexchange.childrensmercy.org/cmh-annual-reports/1017/thumbnail ...
Children\u27s Mercy Hospital
core  

Clinical Significance of Acute Kidney Injury in Idiosyncratic Drug‐Induced Liver Injury: A Multicentric Propensity Scores Matched Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Clinical significance of acute kidney injury in idiosyncratic drug‐induced liver injury: a multicentric propensity scores matched study. Evidence about the role of acute kidney injury (AKI) in idiosyncratic drug‐induced liver injury (DILI) is still scarce.
José María Pinazo‐Bandera   +15 more
wiley   +1 more source

Children\u27s Mercy Annual Report 2003

open access: yes, 2004
Annual report for The Children\u27s Mercy Hospital in Kansas City MO, a pediatric medical center.https://scholarlyexchange.childrensmercy.org/cmh-annual-reports/1014/thumbnail ...
Children\u27s Mercy Hospital
core  

Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Descriptions of how pediatric‐focused institutions implement pharmacogenomic testing are scarce, and often not differentiated from adult‐focused institutions. We aimed to provide a detailed description of how pediatric‐focused institutions across the world implemented pharmacogenomic testing in clinical practice.
Laura B. Ramsey   +15 more
wiley   +1 more source

A Precise Activity System for Pharmacogenetics Based on Estimation of CYP2D6 Allelic Percentage Activity from the International CEPAM Database

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The polymorphic enzyme CYP2D6 contributes to the metabolism of many frequently prescribed drugs, causing substantial variability in drug exposure and treatment outcomes. Genotype‐based dosing recommendations currently rely on drug‐agnostic categorical CYP2D6 allele activity values (AVs), potentially leading to imprecise CYP2D6 phenotype classification ...
Fenja Klima   +90 more
wiley   +1 more source

Children\u27s Mercy Hospital Annual Report 2007

open access: yes, 2008
Annual report for The Children\u27s Mercy Hospital in Kansas City MO, a pediatric medical center.https://scholarlyexchange.childrensmercy.org/cmh-annual-reports/1001/thumbnail ...
Children\u27s Mercy Hospital
core  

Is the EU Sustainable Finance Disclosure Regulation (SFDR) an Opportunity or a Boundary for European Thematic Mutual Funds? A Difference‐in‐Differences Approach

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT The EU Sustainable Finance Disclosure Regulation (SFDR) introduces an ESG‐product classification (Article 8 and 9) to harmonize sustainability‐disclosure standards. However, the SFDR does not specify the sustainability practices of these products.
Mercedes Alda
wiley   +1 more source

Board Composition and Corporate Waste Generation: A Cross‐Country Analysis of Tenure, Cultural Diversity, and Director Skills

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Corporate waste generation is a material environmental outcome embedded in firms' production technologies, process design, resource use, and managerial execution. Although boards do not directly manage operational waste, they may shape waste‐related outcomes through strategic oversight, environmental investment approval, target‐setting, and ...
Hala Zaidan   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy